Cargando…

Patients Lost after Anti-HCV-Positive Finding in a Tertiary Care University Hospital: Increased Awareness and Action is Necessary to Eradicate HCV

OBJECTIVES: Though there is a global effort to eradicate hepatitis C infection (HCV), several obstacles remain. Many patients infected with the virus are not detected or go untreated. The goal of this study was to identify any barriers to treatment and any difficulties contributing to the eliminatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akkuzu, Mustafa Zanyar, Sezgin, Orhan, Yaraş, Serkan, Özdoğan, Osman, Yılmaz, İbrahim, Üçbilek, Enver, Ateş, Fehmi, Altıntaş, Engin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192297/ https://www.ncbi.nlm.nih.gov/pubmed/32377110 http://dx.doi.org/10.14744/SEMB.2019.46656

Ejemplares similares

Controlling Nutritional Status (CONUT) Score and Prognostic Nutritional Index (PNI) Are Good Candidates for Prognostic Markers for Acute Pancreatitis
por: Akkuzu, Mustafa Zanyar, et al.
Publicado: (2022)

Effectiveness of Sedoanalgesia in Percutaneous Liver Biopsy Premedication
por: Sezgin, Orhan, et al.
Publicado: (2017)

EP-01: Association of genetic polymorphisms of OATP with susceptibility to hepatocellular carcinoma in hepatitis C patients who achieved SVR by direct acting antivirals
por: Altintas, Zuhal Mert, et al.
Publicado: (2021)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Validity of modified early warning, Glasgow Blatchford, and pre-endoscopic Rockall scores in predicting prognosis of patients presenting to emergency department with upper gastrointestinal bleeding
por: Bozkurt, Seyran, et al.
Publicado: (2015)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
por: Brochado, Óscar, et al.
Publicado: (2021)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
por: Marino, Andrea, et al.
Publicado: (2021)

HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study
por: Dilbaz, Nesrin, et al.
Publicado: (2023)

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
por: Sabbatini, Massimo, et al.
Publicado: (2018)

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
por: Nahon, Pierre, et al.
Publicado: (2021)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
por: Spaziante, Martina, et al.
Publicado: (2021)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
por: Luo, Yang, et al.
Publicado: (2020)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
por: Álvarez, Beatriz, et al.
Publicado: (2020)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2018)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Hosui, Atsushi, et al.
Publicado: (2021)

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
por: Semmler, Georg, et al.
Publicado: (2021)

Cholangiocellular carcinoma occurrence after HCV eradication therapy: case series and review of the literature
por: Cerban, Razvan, et al.
Publicado: (2022)

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
por: Tajiri, Kazuto, et al.
Publicado: (2023)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Effect of HLA on Hepatitis C Virus Clearance and Persistence in Anti-HCV-positive End-stage Renal Disease Patients
por: Ocal, Serkan, et al.
Publicado: (2014)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3410sqr9f9h4e63pt698lkd0kc